Will Soghikian

Will Soghikian is a Senior Research Analyst covering Emerging Immunology at Leerink Partners.

Mr. Soghikian joined Leerink Partners in 2020 as an Associate on the firm’s biotechnology research team, where he supported the firm’s coverage of small- and mid-cap companies in the Rare Disease sector. He was subsequently promoted to Vice President on the Rare Disease team and later to Senior Research Analyst covering Emerging Immunology. His work focuses on evaluating clinical data, therapeutic differentiation, competitive dynamics, and commercial potential across inflammatory and immune-mediated diseases.

Mr. Soghikian holds a BA from Colby College.